The intersection of documentary filmmaking and traditional narrative performance has reached a contentious turning point as Amanda Seyfried seeks unprecedented awards recognition for her portrayal of Theranos founder Elizabeth Holmes in the genre-bending film You Can See Everything. Directed by Nathan Fielder and Lance Oppenheim, the project has ignited a vigorous debate within the entertainment industry regarding the eligibility of hybrid performances for Academy Awards and other prestigious accolades. As major voting bodies finalize their stances, the film stands as a litmus test for how institutions categorize performance art in an era where the lines between objective documentary footage and scripted reenactment are increasingly blurred.
Chronology of the Eligibility Dispute
The journey of You Can See Everything from an experimental project to an awards-season powerhouse began with its surprise premiere at the Telluride Film Festival on September 6. Following the screening, the film’s unique structure—which utilizes Seyfried to bridge the gap between archival footage and stylized, cinematic reenactments—garnered immediate critical attention. However, the unconventional nature of the production created a procedural logjam for awards organizers.
In the months following the premiere, various guilds and academies were forced to confront the lack of precedent for a documentary-based acting nomination. The Critics Choice Awards served as the first major body to break with tradition, formally declaring Seyfried eligible for a Best Supporting Actress nomination. Conversely, the Golden Globes, BAFTA, and the Screen Actors Guild (SAG) Awards issued rulings of ineligibility, citing the documentary nature of the film as a disqualifying factor. SAG-AFTRA, which governs the Actor Awards, initially encouraged distributor A24 to file a formal appeal to contest this decision. However, industry insiders familiar with the studio’s strategy indicate that A24 has opted to bypass an appeal with the guilds, choosing instead to focus its resources and political capital entirely on the Academy of Motion Picture Arts and Sciences (AMPAS).
Institutional Framework and Academy Rules
The focus now shifts to the Academy’s upcoming review process. Under current regulations governing the Best Documentary Feature category, films are permitted to qualify for additional honors if they meet specific criteria. Crucially, the Academy’s bylaws state that the Actors Branch Executive Committee holds the authority and responsibility to resolve questions of eligibility.
Historically, the Academy has shown flexibility regarding performance in non-fiction works, provided the individual received an on-screen credit. Sources close to the Academy’s internal deliberations suggest that A24 has received positive signals from representatives within the Actors Branch, hinting that a nomination for Seyfried is not only possible but potentially welcomed by the committee. The underlying logic appears to be that the Academy lacks a vested interest in excluding high-caliber performances, provided the film is technically eligible for Academy consideration. The official determination from the executive committees is expected in early December, following the submission deadline.
Supporting Data and Commercial Success
The case for Seyfried’s recognition is bolstered by the film’s exceptional commercial and critical performance. You Can See Everything currently holds a 96 percent approval rating on Rotten Tomatoes, signaling overwhelming critical consensus. Commercially, the film has defied the traditional limitations of the documentary genre, becoming only the fourth documentary in history to top the domestic box office. With a worldwide gross exceeding $80 million and a sustained presence in nearly 2,500 theaters, the film has transcended the niche audience typical of documentaries, achieving the reach and cultural penetration usually reserved for major studio tentpoles.
The film’s influence has been further solidified by a rigorous promotional circuit. Fielder and Oppenheim have been conducting a series of high-profile post-screening Q&As in the United Kingdom, engaging with key Academy and BAFTA voters. These events, moderated by figures such as Olivia Wilde, have attracted a significant industry cross-section, including Academy Award winners and nominees like Cate Blanchett, Riz Ahmed, and director Alex Garland. This grassroots-style campaigning among industry peers is a strategic move to normalize the film’s inclusion in general awards categories, including the elusive Best Picture nomination.
Implications for the Documentary Genre
The debate surrounding Seyfried’s performance touches on a broader trend in filmmaking: the adoption of "docu-drama" elements to enhance the emotional impact of factual narratives. Traditionalists argue that honoring an actor in a documentary could dilute the integrity of the documentary category, which is intended to celebrate the capture of objective reality. Proponents, however, argue that the "performance" is an essential layer of storytelling in modern non-fiction.
Seyfried, who previously received an Oscar nomination for her work in Mank (2020), has acknowledged the complexity of the situation. In her analysis of the film, she notes that the reenactments were designed to be seamless, intended to ground the viewer in the psychology of Elizabeth Holmes rather than call attention to the artifice of the production. "The fact that actors who I respect have experienced it almost as if it’s her is the most incredibly flattering thing," Seyfried noted. She argues that her presence in the film provides a necessary emotional anchor that allows the audience to navigate the dense, often technical history of the Theranos scandal.
Strategic Campaigning and Future Precedent
As the campaign enters its final phase, Seyfried has committed to a full, albeit balanced, promotional schedule. Despite personal challenges throughout the year, the actor maintains that she is invested in the film’s success, not merely for the prospect of an individual award, but to advocate for the "brave" filmmaking that Fielder and Oppenheim have championed.
If Seyfried were to secure an Academy nomination, it would establish a landmark precedent, potentially opening the door for future performances in hybrid films to be considered on equal footing with those in traditional narrative features. This would represent a significant shift in the Academy’s institutional culture, reflecting a more fluid understanding of cinematic storytelling.
From a structural perspective, the success of the campaign rests on the willingness of voters to decouple the "documentary" label from the nature of the performances contained within. A24’s strategy is built on the premise that the film is not merely a record of events, but a cinematic experience defined by the craft of its participants. Whether the Actors Branch Executive Committee agrees that this constitutes a performance worthy of an Oscar nomination remains the pivotal question of the current awards season.
Conclusion
The situation surrounding Amanda Seyfried and You Can See Everything serves as a barometer for the evolving landscape of film awards. As the industry grapples with the definition of documentary craft, the Academy’s decision will likely influence production choices for years to come. By pushing the boundaries of what constitutes a "performance" in a documentary, Fielder, Oppenheim, and Seyfried have challenged the gatekeepers of film history to reconsider the rigid boxes in which they categorize cinematic achievement. As the December deadline for official determinations approaches, the industry watches with anticipation, aware that a decision in favor of eligibility could fundamentally redefine the criteria for the most prestigious honors in film.

